Company intelligence / Profile preview

MDClone

Ownership: Private
Development stage: Commercial

Overview

MDClone provides a commercial, award-winning healthcare data analytics and synthetic data generation platform (ADAMS Platform) that enables secure, privacy-preserving access to real-world clinical information for research, quality improvement, and operational innovation. The company has been recognized with multiple industry awards for its impact on healthcare outcomes through rapid insights from granular clinical information.

Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

Intermountain HealthcareSheba Medical CenterWashington University School of Medicine in St. LouisUniversity of Chicago Medical CenterVHA Innovation Ecosystem (U.S. Department of Veterans Affairs)National Institutes of Health (NIH)The Ottawa HospitalJewish General Hospital (Canada)Universitätsspital Basel in partnership with Roche

Beyond the preview

Go deeper on MDClone.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MDClone.

Explore the full profile